Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Sernova Biotherapeutics Inc. (SEOVF) had Debt to Capital Ratio of -0.02 for the most recently reported fiscal quarter, ending 2026-04-30.
| Income Statement Financials | |
-- |
|
$-2.35M |
|
-- |
|
-- |
|
$1.67M |
|
$-1.67M |
|
$-0.68M |
|
$-2.35M |
|
$-2.35M |
|
$-2.35M |
|
$-2.35M |
|
$-2.35M |
|
$-2.35M |
|
$-1.67M |
|
$-1.67M |
|
351.12M |
|
351.12M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$1.11M |
|
$0.01M |
|
$0.01M |
|
$1.12M |
|
$7.98M |
|
$0.17M |
|
$0.17M |
|
$8.15M |
|
$-15.79M |
|
$-7.03M |
|
$-7.03M |
|
377.64M |
|
| Cash Flow Statement Financials | |
$-2.37M |
|
-- |
|
$2.95M |
|
$0.19M |
|
$0.77M |
|
$0.57M |
|
$0.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.14 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-0.02 |
-0.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.37M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
14.90% |
|
33.49% |
|
-210.41% |
|
34.30% |
|
$-0.02 |
|
$-0.01 |
|
$-0.01 |
|